title: The effect of epitestosterone on gonadotrophin synthesis and secretion.
abstract: The effects of 3-week treatment with increasing doses of epitestosterone (ET) on gonadotrophin gene expression and secretion, on testosterone and 5 alpha-dihydrotestosterone (DHT) levels, and on the weight of testes and prostates, were studied in intact adult male rats. The hormones were delivered by means of silastic capsules of different lengths filled with the steroid. One group of rats received testosterone (T) instead of ET, to compare the results with previous studies concerning the testosterone effect. The controls were given capsules with glucose only. Treatment with ET, as well as with T, significantly reduced the weights of prostates. When the data from ET-treated rats and controls were combined, a significant negative correlation (P < 0.001) was found between the weight of prostates and serum ET. T, in contrast to ET, also decreased significantly the weights of testes, ET treatment caused a significant reduction of serum T levels but only an insignificant decline of DHT levels, independent of the dose. Serum and pituitary (p) luteinizing hormone (LH) levels in the ET-treated rats did not change. Pituitary mRNA contents for the beta LH subunit (beta LH-mRNA) showed a dose-dependent significant increase, up to 170% (P < 0.01), with ET treatment. pFSH decreased with the lowest ET (2 cm) dose (P < 0.05), but no change was observed with the other doses. The mRNA for the common alpha-subunit also increased with the ET load. In conclusion, ET acts at several sites in the regulation of gonadotrophin formation and release. It enhances the steady-state mRNA levels of both gonadotrophins in the pituitary.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institute of Endocrinology, Prague, Czech Republic.
authors.forename: O
authors.initials: O
authors.lastname: Lapcik
authors.forename: A
authors.initials: A
authors.lastname: Perheentupa
authors.forename: M
authors.initials: M
authors.lastname: Bicikova
authors.forename: I
authors.initials: I
authors.lastname: Huhtaniemi
authors.forename: R
authors.initials: R
authors.lastname: Hampl
authors.forename: L
authors.initials: L
authors.lastname: Starka
mesh_terms: D000818:Animals; D013196:Dihydrotestosterone / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004845:Epitestosterone / Q000494:pharmacology*; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D015292:Glycoprotein Hormones, alpha Subunit / Q000235:genetics; D006065:Gonadotropins, Pituitary / Q000378:metabolism*; D017403:In Situ Hybridization; D007986:Luteinizing Hormone / Q000235:genetics / Q000378:metabolism; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism; D011467:Prostate / Q000187:drug effects*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013737:Testis / Q000187:drug effects; D013739:Testosterone / Q000097:blood
chemical_list: D015292:Glycoprotein Hormones, alpha Subunit; D006065:Gonadotropins, Pituitary; D012333:RNA, Messenger; D013196:Dihydrotestosterone; D013739:Testosterone; D004845:Epitestosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone